April 2025
Includes: Remembering Bob Phillips, Enzalutamide vs ADT Slows Sexual Decline, Checking PSA levels too soon after surgery can lead to overtreatment,
Wellspring – No One Has to Face Cancer Alone
Scott Patterson, centre manager for Carma House, joins us to talk about Wellspring Alberta, its history, how it has evolved over the years to reach people across Alberta and the litany of services and supports it offers those dealing with cancer.
March 2025
Includes: Remembering Frank Atlin, Radiation side-effects predict future issues, Urine-based test detects cancer, Hormonal therapy on satisfaction rates after penile prosthesis
February 2025
Includes: Testosterone Therapy May Not Up Recurrence, Additional prostate cancer treatment may adversely affect quality of life, Novartis: A New Treatment for PC, and more.
January 2025
Includes: Happy New Year! A New Treatment for Prostate Cancer, New way to ‘starve’ prostate cancer tumors at cellular level, Can sardines fight against cancer?
December 2024
Includes: Enzyme study, Microwave ablation, Docetaxel improves survival, Prostate Cancer overtreatment, Mushroom supplement, Omega-3 protects against cancer, and more!
“Now What?” – Living with Prostate Cancer and Thriving
Counselling Therapist Jeremiah La Follette joins us for a motivational talk about how to turn the anticipatory grief of a prostate cancer diagnosis into a source of strength and power by using pragmatic thinking and step by step action – to thrive beyond diagnosis as a warrior.
November 2024
Includes: How to deal with prostate cancer day to day, Nanoparticle Therapy Offers New Hope, New Treatment for Aggressive Prostate Cancer, and more!
Embracing Technological Advances in Cancer Screening
Sean Secord, VP of Clinical Engagement at Nanostics Inc. comes to speak of the groundbreaking work that has been done to enhance the precision of PSA and MRI testing using machine learning under the new ClarityDX service.
October 2024
Includes: ClarityDX, New prostate biopsy technique lowers infection risk, What drugs to use first, Trial could lead to new ‘gold standard’ test for PC, and more!